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Abstract
Background: Enterococci are increasingly associated with opportunistic infections in Humans but the role of the
oral cavity as a reservoir for this species is unclear. This study aimed to explore the carriage rate of Enterococci in
the oral cavity of Tunisian children and their antimicrobial susceptibility to a broad range of antibiotics together
with their adherence ability to abiotic and biotic surfaces.
Results: In this study, 17 E. faecalis (27.5%) and 4 E. faecium (6.5%) were detected. The identified strains showed
resistance to commonly used antibiotics. Among the 17 isolated E. faecalis, 12 strains (71%) were slime producers
and 5 strains were non-producers. Among the 4 E. faecium, 2 strains were slime producers. All the tested strains
were able to adhere to at least one of the two tested cell lines. Our result showed that 11 E. faecalis and 2 E.
faecium strains adhered strongly to Hep-2 as well as to A549 cells.
Conclusions: Drugs resistance and strong biofilm production abilities together with a high phenotypic adhesion to
host cells are important equipment in E. faecalis and E. faecium which lead to their oral cavity colonization and
focal infections.
Background
Enterococci are normal commensals Gram-positive cocci
that inhabit the gastrointestinal tract and the human
oral cavity [1]. The increasing interest to Enterococci in
clinical microbiology is linked to their high level intrin-
sic resistance to currently available antibiotics [2]. Enter-
ococcus faecalis is responsible for up to 90% of human
enterococcal infections [3]. However, Enterococcus fae-
cium accounts for the remainder of infections caused by
Enterococci spp. [1]. Data on oral prevalence of E. faeca-
lis vary widely in different studies [4] which ranged
from 0 to 50% depending on the oral source of the
tested specimens (saliva, root canals, plaque) and the
studied populations [5]. Sedgley et al., [4] reported the
presence of E. faecalis in 29% of oral rinse samples and
22% in gingival sulcus samples collected from 41 endo-
dontic subjects. Recently, drugs resistance in E. faecalis
and E. faecium and their possible contribution to
horizontal gene transfer underline the growing attention
being paid to Enterococci in the oral cavity [6].
To date, E. faecalis, are not considered to be part of
the normal oral microbiota [7]. However it has been
considered as the most common species recovered from
teeth with failed endodontic treatment [8] and to be the
predominant infectious agent associated with secondary
endodontic infections [9]. E. faecalis was shown to
reside within different layers of the oral biofilm leading
to failure of endodontic therapy [10]. These biofilms
may contain up to several hundred bacterial species
[11]. Enterococci in biofilms are more highly resistant to
antibiotics than planktonically growing strains [12]. The
possible role of adhesion and cells invasion as virulence
factor associated with enterococcal infections has been
reported [13]. Their capacity to bind to various medical
devices has been associated with their ability to produce
biofilms [14].
The attachment of different E. faecalis strains to sev-
eral extracellular matrix proteins has been reported [15].
Bacterial adherence to host cells such as human urinary
tract epithelial cells [16] and Girardi heart cells [17] was
recognized as the initial event in the pathogenesis of
many infections.
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describe the Enterococci prevalence in the oral cavity of
Tunisian children (caries active and caries free), their
antimicrobial susceptibility to a broad range of antibio-
tics together with their adherence ability to abiotic and
biotic surfaces.
Methods
Patients and Bacterial strains
The study was done on 62 children (34 caries active and
28 caries free) from the Dentistry Clinic of Monastir,
Tunisia. The age group selected for the present investi-
gation was about 4 to 12 years. Ethical clearance was
taken prior to the commencement of study. Written
informed consent was obtained from the parents of all
participants. All clinical procedures were approved by
the Ethical Committee of the Faculty of Medicine, Mon-
astir University, Tunisia. A detailed medical and dental
history was obtained from each parent. The criteria for
inclusion were: no antibiotic treatment during the 4
weeks previous to sampling, no use of mouth rinses or
any other preventive measure that might involve expo-
sure to antimicrobial agents and no systemic disease.
Samples were taken from the oral cavity of each
patient with a sterile swab. After incubation in brain
heart infusion (BHI) medium during 2 h, the swab was
plated on Bile Esculin Agar plates. Suspected colonies of
Enterococci were tested for their positive Gram stain
and catalase reaction (Oxoid, Basingstoke, UK).
Species identification was confirmed using API 20
Strep strips (Bio-Merieux, France) according to the
manufacturer’s recommendation and the results were
read using an automated microbiological mini-API (Bio-
Merieux, France).
Molecular detection of oral Enterococci
Genomic DNA was extracted using a Wizard Genomic
Purification Kit (Promega, Lyon, France). The presence
of oral Enterococci was detected by polymerase chain
reaction (PCR) using specific primers targeted for E. fae-
calis; E1, 5’-ATC AAG TAC AGT TAG TCT-3’ and E2,
5’-ACG ATT CAA AGC TAA CTG-3’[18]. Primers for
E. faecium EM1A, 5’-TTG AGG CAG ACCAGA TTG
ACG-3’ and EM1B, 5’-TAT GAC AGC GACTCC GAT
TCC-3’ [19]. PCR mixture (25 μl) contained 1 mM for-
ward and reverse primers, dNTP mix (10 mM each of
dATP, dCTP, dGTP and dTTP), 1 U of GO Taq DNA
polymerase (Promega, USA), 5 μl green Go Taq buffer
(5X), and DNA template (50 ng).
PCR products (5 μl) were analyzed on 1% (wt/v) agarose
gel stained with ethidium bromide (0.5 μg/μl), visualized
under ultraviolet transillumination and photographed
using gel documentation systems InGenius (Syngene,
USA).
Antimicrobial susceptibility testing
Susceptibility to antibiotics was determined using the
disc diffusion assay on Muller Hinton agar plates sup-
plemented with 5% defibrinated sheep blood, according
to the “Comité de l’antibiogramme de la Société fran-
çaise de microbiologie” [20]. using the following antibio-
tics (diffusible amount): PenicillinG (10 UI), Amoxicillin
(25 μg), Ampicillin (10 μg), Amoxicillin/Clavulanic acid
(20/10 μg), TIC: Ticarcillin (75 μg), Cefalotin (30 μg),
Cefsulodin (30 μg), Ceftazidime (30 μg), Amikacin (30
μg), Gentamicin (500 μg), Kanamycin (1000 μg), Tobra-
mycin (10 μg), Streptomycin (500 μg), Erythromycin (15
UI), Lincomycin (10 μg), Bacitracin (10 UI), Colistin (10
μg), Trimethoprim-Sulfamethoxazole (1.25/23.75 μg),
Nalidixic acid (30 μg), Ciprofloxacin (5 μg), Ofloxacin (5
μg), Nitroxolin (20 μg) and Vancomycin (30 μg).
After 18 h of incubation at 37°C, inhibition zone dia-
meters around each disc were measured and the strains
were categorized as resistant, intermediate resistant, or
susceptible to the antimicrobial agents based on the
inhibition zone size [20].
Phenotypic characterization of bacteria-producing slime
Qualitative Biofilm formation was studied by culturing
strains on Congo red agar plate (CRA) made by mixing
36 g saccharose (Sigma Chemical Company, St. Louis,
MO) with 0.8 g Congo red in one litre of Brain heart
infusion agar (Biorad, USA) and incubated at 37°C for
24 h under aerobic conditions [21].
Results were interpreted as follows: Very black, black
and almost black colonies on CRA, were considered to
be normal slime-producing strains, while very red, red
and bordeaux were classified as non-slime-producing
strains [22].
Semi quantitative adherence assay
Quantitative Biofilm production by the isolated strains
was determined using a semi-quantitative adherence
assay as described previously [13,23].
An overnight culture grown in BHI at 37°C was
diluted to 1:100 in BHI with 2% glucose (w/v). A total
of 200 μl of these cell suspensions was transferred in a
U-bottomed 96-well microtiter plate (Nunc, Roskilde,
Denmark). Wells with sterile BHI alone was served as
negative control. Each strain was tested in triplicate.
The plates were incubated aerobically at 37°C for 24 h
than the microtiter wells were washed twice with phos-
phate-buffered saline (PBS) and dried. Adherent bacteria
were fixed with 95% ethanol and stained with 1% (w/v)
crystal violet solution (Merck, France) for 5 min. The
microplates were washed, air-dried and the optical den-
sity of each well was measured at 570 nm (OD570) using
an automated Multiskan reader (GIO. DE VITA E C,
Rome, Italy).
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producer (OD570 < 0.120); +: weak producer (0.120 <
OD570 <0 . 2 4 0 ;+ + :p r o d u c e r( 0 . 2 4 0<O D 570 <0 . 5 )a n d
+++: high producer (OD570 > 0.5) [24].
Adherence to human epithelial cells
Human epidermoid carcinoma epithelial cells (Hep-2;
ATCC CCL-23) and the respiratory epithelial cell line
(A549) were cultured in Dulbecco’s modified Eagle med-
ium (DMEM) supplemented with 10% foetal calf serum
(GIBCO-BRL) containing 1% penicillin (5 μg/ml) and
streptomycin (100 μg/ml) and incubated with 5% CO2
at 37°C.
Cells (Hep-2 and A549) were seeded at a density of 5
×1 0
5 /ml on glass coverslips placed in 24-well plates.
All experiments were performed at 85-90% confluent
cell monolayers. Prior to each experiment, the mono-
layer was washed with PBS and incubated with DMEM
medium without antibiotics for 24 h. Overnight bacterial
cultures were diluted at 1/100 into BHI broth and incu-
bated at 37°C with agitation for approximately 2 h until
the bacteria reached mid-log-phase. An aliquot of 100 μl
of bacterial suspension of a density corresponding to
approximately 2 × 10
6 CFU/ml was added to each cell.
After incubation at 37°C for 3h, the coverslips were
washed three times with PBS, fixed with methanol for
20 min, stained with Giemsa solution for 20 min and
washed three times with PBS. Bacterial adherence to the
cells was determined by light microscopy.
For each coverslip, a minimum of 800 cells was
inspected to determine the percentage of infected cells,
and next, 60-100 cells with bacteria were inspected to
assess the number of cell associated bacteria. For each
strain, two independent experiments were performed
with two coverslips each [25]. Uninfected cells were
included as a negative control.
Statistical analysis
Statistical analysis was performed on SPSS v.17.0 statis-
tics software. Pearson’sc h i - s q u a r ec2 test was used to
assess inter-group significance. In addition Statistical
significance was set at P < 0.05.
Results
Molecular identification of oral Enterococci
In this study 113 Gram positive cocci were isolated from
the oral cavity of 62 Tunisian children. Molecular iden-
tification using specific primer showed the presence of
17 E. faecalis giving a 941 DNA base pair product upon
amplification (Figure 1) and 4 E. faecium giving a 658
DNA base pair product (Figure 2).
Consequently, the prevalence of E. faecalis and E. fae-
cium were 27.5% (17/62) and 6.5% (4/62) respectively
(Table 1).
In the carious group population, the prevalence of
E. faecalis and E. faecium were 46.9% (15/32) and 9.5%
(3/32). However, in the caries-free one, the prevalence of
E. faecalis and E. faecium were 7% (2/28) and 3.5% (1/28)
respectively.
Antimicrobial susceptibility testing
The antibiotic susceptibility of the isolated oral Entero-
cocci showed the presence of multiresistant strains
(Table 1).
Resistance profiles of Enterococci to the antimicrobial
agents were as follows: penicillin, ticarcillin, Cefsulodin,
Ceftazidime, Amikacin, Tobramycin and Streptomycin,
100%; Colistin, 91%, Trimethoprim-Sulfamethoxazole,
71%, Ampicillin, 33%, Amoxicillin, 29%, Amoxicillin/
Clavulanic acid, Gentamicin and Kanamycin, 24%.
Furthermore all the strains were susceptible to Cefalotin
and Vancomycin.
Phenotypic characterization of bacteria-producing slime
Among the 17 isolated E. faecalis, 12 strains (71%) were
slime producers developing almost black, black or very
1     2    3      4     5      6   
1000 bp 
500 bp 
300 bp 
50 bp 
941 bp
Figure 1 Agarose gel electrophoresis of polymerase chain
reaction (PCR) amplification of Enterococcus faecalis gene. Lane
1 and 6: 25 bp DNA molecular size marker; Lane 2, negative
control; lanes 3 to 6, PCR amplicons obtained with DNA
amplification of Enterococcus faecalis:l a n e3 ,B 5 4 ;l a n e4 ,B 9 ;
lane 5, B310; lane 6, B403.
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strains were non-producers developing red or bordeaux
colonies (Table 2).
Among the 4 E. faecium, 2 strains were slime produ-
cers developing almost black (B215) and very black
colonies (B577) on the CRA plate.
Semi quantitative adherence assay
All the examined strains were biofilm producers using
the semi quantitative adherence assay (Table 2) and the
OD570 were above 0.12, i.e. the value recognized as the
limit under which strains were considered non-produ-
cers [24]. Six isolates showed an OD570 higher than 0.5
(indicated as +++ in Table 2), this being the threshold
for strongly biofilm producers.
Adherence of oral Enterococci to Hep-2 and A549 cells
Here, we analyzed the ability of Enterococcus strains iso-
lated from oral cavity to adhere to the human epidermoid
cancer (Hep-2) and the human lung adenocarcinoma
epithelial (A549) cell lines. All the tested strains are able
to adhere to at least one of the two tested cell lines.
Our result showed that 11 E. faecalis and 2 E. faecium
s t r a i n sa d h e r e ds t r o n g l yt oH e p - 2a sw e l la st oA 5 4 9
cells (Table 2). Two strains were moderately adherent to
both cells lines. In addition three strains were strongly
adherent to Hep-2 cells while moderately adherent to
A549 cells (Table 2).
Discussion
In the last decade, several studies have focused on the
relationship between periodontal diseases and oral bac-
teria. The current investigation examined the prevalence
of Enterococci in the oral cavity of Tunisian children
using specific primers.
In this study, 21 Enterococci (33.9%) among 113
Gram positive cocci were isolated and identified from
t h eo r a lc a v i t yo f6 2c h i l d r e n .N i n e t e e nEnterococci
were isolated from carious lesion (55.8%) and two
from caries free (7%). Similar results have been
reported by Gold et al., [5] suggesting that Enterococci
1      2    3      4     5      6   
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Figure 2 Agarose gel electrophoresis of polymerase chain
reaction (PCR) amplification of Enterococcus faecium gene. Lane
1 and 6: 50 bp DNA molecular size marker; Lane 2, negative control;
lanes 3 to 6, PCR amplicons obtained with DNA amplification of
Enterococcus faecium: lane 3, B333; lane 4, B346; lane 5, B577;
lane 6, B215.
Table 1 Antimicrobial susceptibility of the oral
Enterococci
Antibiotics No. (%)
a of resistant strains
E. faecalis
(n = 17)
E. faecium
(n = 4)
Total
(n = 21)
PENICILLINS P 17 (100) 4 (100) 21 (100)
Amx 6 (35) 0(0) 6 (29)
AM 6 (35) 1 (25) 7 (33)
AMC 4 (25) 1 (25) 5 (24)
TIC 17 (100) 4 (100) 21 (100)
CEPHALOSPORINS CF 0(0) 0 (0) 0 (0)
CFS 17 (100) 4 (100) 21 (100)
CAZ 17 (100) 4 (100) 21 (100)
AMINOGLYCOSIDS AN 17 (100) 4 (100) 21 (100)
GM 4 (25) 1 (25) 5 (24)
K 5 (29) 0 (0) 5 (24)
TM 17 (100) 4 (100) 21 (100)
S 17 (100) 4 (100) 21 (100)
MACROLIDS E 17 (100) 4 (100) 21 (100)
LINCOSAMIDS L 17 (100) 4 (100) 21 (100)
POLYPEPTIDS B 17 (100) 4 (100) 21 (100)
CS 16 (94) 4 (100) 20 (95)
SULFAMIDS-TRIMETHOPRIME SXT 12 (71) 3 (75) 15 (71)
GLYCOPEPTIDS VA 0 (0) 0 (0) 0 (0)
QUINOLONES NA 17 (100) 4 (100) 21 (100)
FLUOROQUINOLONES CIP 17 (100) 4 (100) 21 (100)
OFX 17 (100) 4 (100) 21 (100)
DIVERS NI 17 (100) 4 (100) 21 (100)
P:PenicillinG, Amx: Amoxicillin, AM: Ampicillin, AMC: Amoxicillin/Clavulanic
acid, TIC: Ticarcillin, CF: Cefalotin, CFS:Cefsulodin, CAZ: Ceftazidime, AN:
Amikacin, GM: Gentamicin, K: Kanamycin, TM: Tobramycin, S: streptomycin, E:
erythromycin, L: Lincomycin, B: Bacitracin, CS: Colistin, SXT: Trimethoprim-
Sulfamethoxazole, VA: Vancomycin, NA: Nalidixic acid, CIP: Ciprofloxacin, OFX:
Ofloxacin, NI: Nitroxolin.
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carious school children.
Data presented in table 1 showed a significantly higher
frequency of E. faecalis (n = 17) than E. faecium (n = 4).
This result was contradictory with a recent study
reported a low prevalence rate of E. faecalis (3.5% to
13.5%) in intraoral sites [26].
Antimicrobial agents are frequently used in dentistry
[27], which may however lead to drug resistance among
the other oral bacteria [28]. In this study, the isolated
strains were examined for their antimicrobial suscept-
ibility to a broad range of antibiotics. Our results
revealed the presence of resistant Enterococci (E. faecalis
and E. faecium) to a wide range of antibiotics such as
penicillin, Ticarcillin, Cefsulodin, Ceftazidime, Amikacin,
Tobramycin, streptomycin, erythromycin, Lincomycin,
Bacitracin, Nalidixic acid, Ciprofloxacin, Ofloxacin and
Nitroxolin (Table 1). This is a serious problem, as it
reduces the number of possible antimicrobial therapies
for dental infections associated to Enterococci.F u r t h e r -
more all the isolated strains were susceptible to Cefalo-
tin and Vancomycin. Resistant Enterococci to currently
available antibiotics pose real therapeutic difficulties [29]
and can lead to the endodontic treatment failures result
[30]. Moreover, transfer of resistance determinants from
Enterococci to other more virulent Gram-positive
bacteria, like staphylococci, has been observed in vitro
[31]. Our previous data supported the presence of resis-
tance oral streptococci [32] and the association of Staphy-
lococcus aureus with dental caries [33] which carried
various antibiotics and disinfectants resistance genes [34].
E. faecalis is responsible for endodontic infections due
to their adherence to dentin collagen, and their resis-
tance to endodontic therapy [26].
Enterococci are the third most common pathogen
isolated from bloodstream infections and the most fre-
quently isolated species in teeth with persistent infection
after root canal treatment [35]. Different bacteriological
studies have evaluated that E. faecalis is present in 29-
46% of root-filled teeth with periapical lesions [36].
These findings highlight the ability of E. faecalis to per-
sist in the post endodontic root canal environment [37].
One of the virulence factors that allow Enterococci to
persist within the oral cavity is biofilm formation. Oral
Enterococci produce virulence factors including aggrega-
tion substances, surface adhesins, lytic enzymes, and
haemolysins [38]. The prevalence of biofilm positive
Enterococci varied worldwide. Many studies have
reported the ability of Enterococcus derived from various
clinical origins to form biofilm [24]. Thus, biofilm
Table 2 Biofilm formation and of oral Enterococci and their adherence to abiotic and biotic surfaces
Strains Identification Origin Phenotypes on CRA Slime production Mean OD595 ± SD *OD595 Adherence
Hep-2 A 549
B347 E. faecalis Caries active AB Producer 0.152 0.003 + Moderately Moderately
B342 E. faecalis Caries active Black Producer 0.955 0.045 +++ Strongly Strongly
B358 E. faecalis Caries active Brd Non-producer 0.224 0.008 + Strongly Strongly
B403 E. faecalis Caries active AB Producer 0.360 0.011 ++ Strongly Strongly
B310 E. faecalis Caries active AB Producer 0.853 0.009 +++ Strongly Strongly
B281 E. faecalis Caries active AB Producer 0.508 0.018 +++ Strongly Strongly
B312 E. faecalis Caries active Black Producer 0.750 0.008 +++ Strongly Strongly
B345 E. faecalis Caries active AB Producer 0.550 0.026 +++ Strongly Strongly
B54 E. faecalis Caries active Black Producer 0.367 0.052 ++ Strongly Strongly
B’381 E. faecalis Caries active Brd Non-producer 0.429 0.002 ++ Strongly Strongly
B9 E. faecalis Caries active Brd Non-producer 0.391 0.002 ++ Strongly Strongly
B366 E. faecalis Caries active Black Producer 0.211 0.004 + Moderately Weakly
B362 E. faecalis Caries active Brd Non-producer 0.261 0.017 + Strongly Moderately
B385 E. faecalis Caries active AB Producer 0.244 0.075 + Strongly Moderately
B361 E. faecalis Caries active AB Producer 0.290 0.249 + Moderately Moderately
B368 E. faecalis Caries free Brd Non-producer 0.202 0.008 + Strongly Strongly
B412 E. faecalis Caries free AB Producer 0.291 0.011 + Strongly Moderately
B336 E. faecium Caries active Red Non-producer 0.228 0.001 + Strongly Strongly
B346 E. faecium Caries active Brd Non-producer 0.181 0.003 + Moderately Moderately
B577 E. faecium Caries active Very Black Producer 0.179 0.035 + Moderately Moderately
B215 E. faecium Caries free AB Producer 1.238 0.011 +++ Strongly Strongly
*Biofilm production: -: non-producer (OD570 < 0.120); +: weak producer (0.120 < OD570 < 0.240; ++: producer (0.240 < OD570 < 0.5); +++: high producer (OD570 >
0.5).
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esis of enterococcal infection.
Our data showed that 71% of E. faecalis and 50% of E.
faecium were slimes producer on CRA plates. Moreover,
all the examined strains were biofilm producers on
microtiter plate (OD570 > 0.120). Statistical analysis
revealed a correlation between the slime production on
CRA and the semi quantitative adherence assay value (P
< 0.001). Similar results have been reported by Arciola
et al., [24] who confirmed that the majority of E. faecalis
isolated from orthopedic implant-related infections are
able to form biofilm.
Quantitative adherence determination showed a wide
range of variation in adherence among strains, and the
one sample-t test revealed a significant difference in
adherence potency between the tested strains (P <
0.001).
A number of adhesion factors of Enterococci have
been identified that confer binding to mucosal and
other epithelial surfaces and facilitate host colonization
[39]. Aggregation substance seems to mediate the speci-
fic binding of Enterococci to intestinal epithelium [40],
renal epithelial cells [41], and macrophages [42] which
increase their intracellular survival [42]. Since Entero-
cocci are among the leading causes of endocarditis, and
also exist as opportunistic bacteria in the oral cavity,
bacterial adherence assay was performed to assess the
binding efficiency of Enterococci to Hep2 and A549
cells.
All the isolated bacteria adhered to host cells. Among
them16 and 13 strains were defined as strongly adherent
to Hep-2 and A549 cells respectively (Table 2) confirm-
ing previous restudy suggesting the adherence ability of
Enterococci to many host cells especially cardiac (GH),
urinary tract epithelial cells (Vero, HEK) and intestinal
cells [43].
At this point, we succeeded to establish a correlation
between the semi quantitative adherence assay and the
adherence potency to Hep2 and A549 cells (P <0 . 0 0 1 ) .
The high adherence level of oral Enterococci to host
cells increases their pathogenecity and confirms the role
of the oral cavity as a reservoir of bacterial pathogens
for focal infections.
Conclusion
In summary, the oral cavity has been shown to be a
reservoir for drug-resistant Enterococci.M o r ei m p o r -
tantly, our findings provide additional evidence for the
persistence and adherence abilities of these bacteria
within the carious lesions. The high rate of drugs resis-
tance, strong biofilm formers and strong adherent to
host cells Enterococci suggests that these three factors
may play an important role in enterococcal infections.
The establishment of such pathogen in the dental
biofilm in addition to its multi-resistance, close attention
should be given to these strains in order to reduce the
risk for development of systemic diseases caused by
Enterococci in other areas of the body.
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